While RET proto-oncogene pathogenic variants are the defining genetic hallmark of hereditary MTC, NGS allows comprehensive analysis of both germline and somatic alterations, offering insights beyond conventional RET testing. This evidence concerns the gene RET and medullary thyroid gland carcinoma.